Stay updated on Amivantamab Clinical Trial in Advanced NSCLC
Sign up to get notified when there's something new on the Amivantamab Clinical Trial in Advanced NSCLC page.

Latest updates to the Amivantamab Clinical Trial in Advanced NSCLC page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedNew revision entries were added for 2026-04-13, 2026-04-09, and 2026-04 (Revision: v3.5.2); older entries from 2026-01-16, 2026-01-15, and 2026-01 (Revision: v3.5.0) were removed.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check32 days agoChange Detected- Revision: v3.5.0 was added to reflect the latest page revision, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check46 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. This appears to be a minor administrative update and does not modify study content.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded a minor site revision tag (Revision: v3.4.2) and removed a general government funding notice; the study details and page content remain unchanged.SummaryDifference0.3%

- Check82 days agoChange DetectedA government funding lapse notice was added indicating possible delays in updates and that the NIH Clinical Center remains open, with links to update status at opm.gov. The page revision tag was updated from v3.4.0 to v3.4.1, and the previous revision tag v3.4.0 was removed.SummaryDifference0.3%

- Check89 days agoChange DetectedGlossary toggle was added and the 'No FEAR Act data' footer note was removed; no changes to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference76%

Stay in the know with updates to Amivantamab Clinical Trial in Advanced NSCLC
Enter your email address, and we'll notify you when there's something new on the Amivantamab Clinical Trial in Advanced NSCLC page.